Pliant Therapeutics Inc. (PLRX)

AI Score

Unlock

1.54

0.04 (2.67%)

At close: Apr 23, 2025, 3:59 PM

1.44

-6.91%

Pre-market: Apr 24, 2025, 05:14 AM EDT

Dividends

No dividend history available for Pliant Therapeutics Inc..

Pro Subscription

Upgrade now for unlimited access to all data and tools.

Dividend Definition

Dividends are payments made by a company to its shareholders, typically derived from its profits. They represent a portion of earnings distributed to investors as a reward for holding shares. Dividends do not account for retained earnings or reinvestments and are therefore different from a company's total profits.

Full Definition

Related Stocks

Company	Dividend Yield

Dividend Rankings

PLRX News

23 hours ago · INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pliant Therapeutics, Inc. - PLRX - accessnewswire.com
1 week ago · INVESTOR ALERT: Pomerantz Law Firm Investigates Claims - On Behalf of Investors of Pliant Therapeutics, Inc. - PLRX - accessnewswire.com
2 weeks ago · PLIANT THERAPT (PLRX) Upgraded to Buy: Here's What You Should Know - zacks.com
2 weeks ago · INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant Therapeutics - accessnewswire.com
3 weeks ago · Pliant Therapeutics: An Activist On Deck - seekingalpha.com
4 weeks ago · PLRX Stock Plunges 89% in 3 Months: Here's What Investors Should Know - zacks.com
1 month ago · INVESTIGATION ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant Therapeutics - accessnewswire.com
1 month ago · Pliant Therapeutics Stock Sinks, Discontinues Mid-Stage Study For Lung Disorder - benzinga.com
1 month ago · The Schall Law Firm Invites Shareholders With Losses In Pliant Therapeutics, Inc. To Join A Securities Fraud Investigation - accessnewswire.com
1 month ago · An Investigation Has Been Launched Into Pliant Therapeutics, Inc. For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law Firm - accessnewswire.com